Abstract
Severe acute respiratory syndrome (SARS)-like WIV1-coronavirus (CoV) was first isolated from Rhinolophus sinicus bats and can use the human angiotensin converting enzyme 2 (ACE2) receptor. In the current study, we investigate the ability of WIV1-CoV to infect Rousettus aegyptiacus bats. No clinical signs were observed throughout the experiment. Furthermore, only four oropharyngeal swabs and two respiratory tissues, isolated on day 3 post inoculation, were found positive for viral RNA. Two out of twelve bats showed a modest increase in coronavirus specific antibodies post challenge. In conclusion, WIV1-CoV was unable to cause a robust infection in Rousettus aegyptiacus bats.
| Original language | English (US) |
|---|---|
| Article number | 727 |
| Journal | Viruses |
| Volume | 10 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2018 |
| Externally published | Yes |
Keywords
- Animal model
- Coronavirus
- Emerging infectious diseases
- WIV1-CoV
ASJC Scopus subject areas
- Infectious Diseases
- Virology
Fingerprint
Dive into the research topics of 'SARS-Like coronavirus WIV1-CoV does not replicate in Egyptian fruit bats (Rousettus aegyptiacus)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS